Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, a new study has found.
In the Women's Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had a statistically significant increase in lung cancer mortality, but not incidence.
Hormone Replacement Therapy
Hormone Replacement Therapy can be likened to an 'oasis in the desert' for women in the throes of menopause.
Advertisement
Other studies with combined hormone therapy have had conflicting results. But the influence of estrogen alone was unclear.
To determine whether use of estrogen alone was associated with lung cancer incidence and increased lung cancer mortality, Rowan T. Chlebowski, of the Los Angeles Biomedical Research Institute, and colleagues, in a post-hoc analysis examined data from a previous randomized, double-blind, placebo-controlled trial in the WHI.
![Human Growth Hormone]( "Human Growth Hormone")
Human growth hormone, otherwise known as somatotropin, stimulates growth, cell reproduction, and bone regeneration.
This trial was conducted in 40 centers in the U.S., in which 10,739 postmenopausal women aged 50-79 years with a hysterectomy were randomly assigned to groups receiving estrogen alone or placebo.
The researchers found there was only one more death from lung cancer in the estrogen group (34 deaths) compared with the placebo group (33 deaths).
Their conclusion was that use of estrogen alone was not associated with lung cancer incidence or death from lung cancer in women with hysterectomies.
The study has been published online August 13 in The Journal of the National Cancer Institute.
Source: ANI
Human Growth Hormone
Human growth hormone, otherwise known as somatotropin, stimulates growth, cell reproduction, and bone regeneration.
Advertisement
This trial was conducted in 40 centers in the U.S., in which 10,739 postmenopausal women aged 50-79 years with a hysterectomy were randomly assigned to groups receiving estrogen alone or placebo.
The researchers found there was only one more death from lung cancer in the estrogen group (34 deaths) compared with the placebo group (33 deaths).
Their conclusion was that use of estrogen alone was not associated with lung cancer incidence or death from lung cancer in women with hysterectomies.
The study has been published online August 13 in The Journal of the National Cancer Institute.
Source: ANI
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemotherapy, cryosurgery or biologic therapy.
Advertisement
 AcneAcne vulgaris, popularly known as 'pimples' or 'zits' is a skin condition affecting most teenagers. | Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
In 2021, Japan has an increased incidence of low birth weight estimated at 9.2% for all births.
The higher suicide risk for bisexual women is associated with increased greater discrimination.
Women over 45 years old taking estrogen pills have a higher likelihood of developing high blood pressure compared to those using transdermal or vaginal formulations.
The new study assessed the beneficial effects of nitroglycerin patches in treating hot flashes in postmenopausal women.
A new study investigated the rate of neural tube defects in predominantly Hispanic-populated women before and after the voluntary fortification of corn masa flour with folic acid.